Home|Journals|Articles by Year|Audio Abstracts
 

Case Report

Ann Med Res. 2011; 18(2): 119-121


A Case of Chronic Prostatitis Presenting with High PSA Levels as a Result of ESBL Producing E. Coli

Ali Beytur*, Yusuf Yakupoğulları**

.




Abstract


Chronic prostatitis is an infection that requires long-term antimicrobial therapy. In this study, a chronic prostatitis case is presented, which was caused by an extended spectrum of beta-lactamase-producing E. coli strain, and progressed with recurrent relapses.

A 72 years old patient who admitted to urology clinic with disuria complaint underwent to advanced medical investigation for malignancy by the measurement of the serum PSA levels above 18 ng/ml. Histopathologic examination of his prostate biopsy samples resulted as chronic inflammation with active focuses, after the urine culture yielded E.coli growth with meaningful colony count.

As the isolate was multidrug-resistant, parenteral carbapenem therapy was commenced for the patient. Although serum PSA levels decreased approximately 3-4 fold while he was receiving antimicrobial therapy, it did elevate to high levels again following the therapy’s end. The patient received 4 cures of antibiotherapy in the current year. He is still under consideration to be given antibiotics in acute phases, with urine culture and serum PSA levels measurements.

Key Words: Prostatitis; E.Coli; PSA.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.